comparemela.com
Latest Breaking News On - Presented today during digestive disease week - Page 1 : comparemela.com
Anokion SA: Anokion Announces New Clinical Data from the Phase 1 ACeD Trial Supporting KAN-101 as a Potential Disease-modifying Treatment for Celiac Disease
Phase 1b/2 Clinical Trial of KAN-101 in Patients with Celiac Disease Underway New Pharmacodynamic and Pharmacokinetic Data to be Presented Today During Digestive Disease Week 2023 Anokion SA
Switzerland
Swiss
Alicia-davis
Deborah-geraghty
Strategic-communications
Celiac-disease
Pharmacokinetic-data
Presented-today-during-digestive-disease-week
Immunological-tolerance-induced
Novel-liver-targeted-therapy
Persists-following-drug-clearance
Digestive-disease-week
vimarsana © 2020. All Rights Reserved.